False-positive mammograms have limited effect on anxiety

Key points
- Women whose mammograms suggest possible breast cancer that is eventually ruled out experience slightly increased anxiety, but that doesn't necessarily affect their overall health, according to a new study.
- Importance False-positive mammograms, a common occurrence in breast cancer screening programs, represent a potential screening harm that is currently being evaluated by the US Preventive Services Task Force.
- What's more, the increased anxiety appears to dissipate within a year, write the researchers in JAMA Internal Medicine.
- "We provide one more piece of evidence that women need to be well informed of the outcome of screenings," Anna Tosteson told Reuters Health.
Women whose mammograms suggest possible breast cancer that is eventually ruled out experience slightly increased anxiety, but that doesn't necessarily affect their overall health, according to a new study.
What's more, the increased anxiety appears to dissipate within a year, write the researchers in JAMA Internal Medicine.
"We provide one more piece of evidence that women need to be well informed of the outcome of screenings," Anna Tosteson told Reuters Health. "Especially women 40 to 49 (years old) need to think about how they would feel about having a false-positive mammogram."
Tosteson is the study's lead author from the Geisel School of Medicine at Dartmouth College in Lebanon, New Hampshire.
False-positives occur when the results of a mammogram suggest possible breast cancer, when in reality no cancer exists. Typically the initial positive test is followed by additional screenings or a more invasive biopsy to look for cancer.
There is about a 61 percent chance that a woman who undergoes yearly mammograms over a decade will have a false-positive during that time, according to Dr. Kurt Kroenke, who wrote an editorial accompanying the new study.
Kroenke is from the Regenstrief Institute, Inc, a nonprofit healthcare research organization in Indianapolis.
Aside from the bother of having additional tests, some policymakers and medical organizations also take into account how much anxiety a false-positive may cause a woman when making recommendations about who should get screened.
For the new study, the researchers used information from 1,028 women who participated in a trial that tested the reliability of a new type of mammogram.
They compared 534 cancer-free women whose mammograms initially suggested breast cancer to 494 women whose screenings were negative from the start.
The women were interviewed after the first mammogram - but typically before they were cleared of a cancer diagnosis - and then a year later.
Immediately after their first mammogram, the women who received false-positive results had more anxiety than those who received a clean bill of health.
On a scale from 20 to 80, with higher scores indicating increased anxiety, women in the false-positive group scored 35, on average, compared to 33 among women in the negative group.
The scores then leveled off to 34 and 33, respectively, after a year.
There was no difference between the groups on a measure of overall health.
The women in the false-positive group also reported being just as likely to undergo another breast screening within the next two years as those who tested negative. Roughly 93 percent in both groups planned to get screened again in that interval.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsBreast Cancer Specialist Presents Positive Results for Triple-Negative Breast Cancer Presurgery Chemotherapy Benefits
A breast cancer specialist and clinical researcher at Women & Infants Hospital of Rhode Island presented research yesterday at the 2014 San Antonio Breast Cancer Symposium showing that adding either the chemotherapy…
16 December 2014
NewsHerceptin found to improve long-term survival of HER2-positive breast cancer patients
VCU Massey Cancer Center physician-researcher Charles E. Geyer, Jr., M.D., was the National Protocol Officer for one component of a large national study involving two National Cancer Institute (NCI)-supported clinical…
16 December 2014
NewsMost elderly women with early stage breast cancer receive a treatment that may not be as effective
A new analysis has found that while clinical trial data support omitting radiation treatments in elderly women with early stage breast cancer, nearly two-thirds of these women continue to receive it. The findings are…






